| | | Unfortunately, this could lead to another class action suit. Just saying, but hoping not.
Agree that the volume today is suggesting that this might be about something else.
Hoping not, but, like Tinfoil, I'm using it to average down.
I do not think we're looking at years, but maybe months, to right the ship on other
indication trials. Given that Anktiva is already approved for one cancer, and has shown
very good early results on others, I'm ok adding more at this point.
Having said that, I'm kinda sure that mgmt. screwed up in some way.
I'm hoping politics is not a part of this, but in this crazy world, who knows.
Let's hope that we hear more, sooner rather than later.
Best |
|
